In our new blog series, “Staff Spotlight”, we’re introducing you to people who are worth a mint to us: Our staff. What would an organisation like ours be without these passionate people who dedicate their work lives (and more) to improving healthcare worldwide—whose everyday mission is to enable all people to access and properly use the medicines they need?
by BOBBI KLETTKE
When 21-year-old Kissa Ojok became pregnant with her first child, she feared for her life. For years, she had heard stories from other women in her community, a rural village in central Uganda, about the pain, suffering—even death—that many before her had endured during pregnancy and childbirth. She had also heard,
Health Action International is, once again, pleased to be in Geneva this week attending the 69th World Health Assembly. If you will be there, too, please plan on attending a side event on ‘Achieving Affordable Access to Health Technologies’, which we are co-organising with the Medicines for Malaria Venture and Oxfam.
The event will be held on Tuesday,
by MOLLY LEPESKA
An ACCISS Study Review of the global insulin market, called ‘Constraints and Challenges in Access to Insulin: A Global Perspective, was published Friday in The Lancet Diabetes & Endocrinology. Co-authored by ACCISS Study leaders, David Beran, Marg Ewen and Richard Laing, the Review describes why insulin is still unattainable for approximately half of all people who need it.
by BOBBI KLETTKE, Communications
Access to medicines is a key component of the human right to health. Although the European Union (EU) and its Member States are committed to universal and equitable access to healthcare, many patients across Europe still suffer inequalities in medicines availability and affordability. This is particularly the case in Eastern European countries.
by TIM REED, Executive Director
Health Action International’s largest-ever team to the 68th World Health Assembly enjoyed a fruitful week of advocacy, which resulted in some major achievements, particularly related to antimicrobial resistance and World Health Organization (WHO) engagement with non-state actors. The annual Assembly was held in Geneva from 18-26 May.
The delegation was comprised of 39 insightful and talented people from ReAct–Action on Antibiotic Resistance,